Dapsone NDC 62332-663

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-663Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0663Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-663-30	62332066330	1 BOTTLE, PUMP in 1 CARTON (62332-663-30) / 30 g in 1 BOTTLE, PUMPMarketed from Oct 30, 2023
62332-663-60	62332066360	1 BOTTLE, PUMP in 1 CARTON (62332-663-60) / 60 g in 1 BOTTLE, PUMPMarketed from Oct 30, 2023
62332-663-90	62332066390	1 BOTTLE, PUMP in 1 CARTON (62332-663-90) / 90 g in 1 BOTTLE, PUMPMarketed from Oct 30, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dapsone
Generic name (nonproprietary): dapsone
Active ingredients: Dapsone — 75 mg/g
Dosage form: Gel
Route: Topical
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215718
Marketing start: Oct 30, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Sulfones (Chemical structure)
Identifiers: Product ID 62332-663_5fa76202-2367-486b-bfe8-73f3dcd5a574SPL ID 5fa76202-2367-486b-bfe8-73f3dcd5a574SPL set ID 2811f7de-13bf-45cd-8413-5b04d11f40ffRxCUI 1741905UNII 8W5C518302UPC 0362332663309
Pharmacologic class: Sulfone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332066330 followed by a unit qualifier and the quantity

Package 62332-0663-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 3, 2025.

Indications (excerpt from the label)

Dapsone gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Dapsone gel, 7.5%, is a sulfone indicated for the topical treatment of acne vulgaris in patients 9 years of age and older ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215718

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215718
Product	Strength	Form · route	Labeler	Product NDC
Dapsone	Dapsone 75 mg/g	GelTopical	Alembic Pharmaceuticals Limited	46708-663